Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069247891> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2069247891 endingPage "521" @default.
- W2069247891 startingPage "518" @default.
- W2069247891 abstract "Summary Two different methods, administered both subcutaneously and intravenously, to reverse intramuscular midazolam‐medetomidine‐ketamine, are evaluated. Eighteen cats were anaesthetized twice each 5 min after premedication with atropine 0.04 mg/kg using midazolam 0.5 mg/kg, medetomidine 0.02 mg/kg and ketamine 2.0 mg/kg intramuscularly in one syringe. Because this study was conducted in co‐operation with a dental prophylaxis project, cats had to be immobilized for approximately 1 h. Therefore, anaesthesia was prolonged with propofol to effect, if necessary. After 68 ± 11 min on average, immobilization was partially reversed by either atipamezole 0.05 mg/kg subcutaneously (group A/SC, n = 7) or intravenously (group A/IV, n = 10), or by atipamezole 0.05 mg/kg and flumazenil 0.05 mg/kg subcutaneously (group AF/SC, n = 10) or intravenously (group AF/IV, n = 9), respectively. These four groups were additionally compared with a non‐reversed group. Recovery time and total time of immobilization (until cats regained a standing position) were not significantly shortened using the antagonists. However, unconsciousness and sedation (expressed through parameters like the time taken to head lifting, crawling, sitting and the return of righting reflex) were significantly shortened by the antagonists, especially if administered intravenously. Abnormal behaviour, such as vocalization, licking, hyperaesthesia, restlessness or salivation, was observed in all groups. However, excitation and hyperaesthesia were not observed in group AF/IV, whereas in this group only intensified salivation occurred. The addition of flumazenil showed no significant difference to atipamezole alone, but subcutaneous administration of atipamezole alone was not sufficient in the dosage used to show an advantage compared to non‐reversed cats." @default.
- W2069247891 created "2016-06-24" @default.
- W2069247891 creator A5014830190 @default.
- W2069247891 creator A5015562219 @default.
- W2069247891 creator A5050569278 @default.
- W2069247891 creator A5050784736 @default.
- W2069247891 creator A5056453276 @default.
- W2069247891 date "2007-10-10" @default.
- W2069247891 modified "2023-10-12" @default.
- W2069247891 title "Partial Antagonization of Midazolam-Medetomidine-Ketamine in Cats – Atipamezole versus combined Atipamezole and Flumazenil" @default.
- W2069247891 cites W1974483724 @default.
- W2069247891 cites W1978342290 @default.
- W2069247891 cites W1987721276 @default.
- W2069247891 cites W2002115284 @default.
- W2069247891 cites W2056700963 @default.
- W2069247891 cites W2120148445 @default.
- W2069247891 cites W2145415608 @default.
- W2069247891 cites W2162608579 @default.
- W2069247891 doi "https://doi.org/10.1111/j.1439-0442.2007.00971.x" @default.
- W2069247891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17931228" @default.
- W2069247891 hasPublicationYear "2007" @default.
- W2069247891 type Work @default.
- W2069247891 sameAs 2069247891 @default.
- W2069247891 citedByCount "10" @default.
- W2069247891 countsByYear W20692478912012 @default.
- W2069247891 countsByYear W20692478912013 @default.
- W2069247891 countsByYear W20692478912014 @default.
- W2069247891 countsByYear W20692478912018 @default.
- W2069247891 countsByYear W20692478912019 @default.
- W2069247891 countsByYear W20692478912021 @default.
- W2069247891 countsByYear W20692478912022 @default.
- W2069247891 crossrefType "journal-article" @default.
- W2069247891 hasAuthorship W2069247891A5014830190 @default.
- W2069247891 hasAuthorship W2069247891A5015562219 @default.
- W2069247891 hasAuthorship W2069247891A5050569278 @default.
- W2069247891 hasAuthorship W2069247891A5050784736 @default.
- W2069247891 hasAuthorship W2069247891A5056453276 @default.
- W2069247891 hasConcept C126322002 @default.
- W2069247891 hasConcept C170493617 @default.
- W2069247891 hasConcept C2775859210 @default.
- W2069247891 hasConcept C2776277131 @default.
- W2069247891 hasConcept C2776312488 @default.
- W2069247891 hasConcept C2776814716 @default.
- W2069247891 hasConcept C2776885963 @default.
- W2069247891 hasConcept C2777953023 @default.
- W2069247891 hasConcept C2778000748 @default.
- W2069247891 hasConcept C2778300832 @default.
- W2069247891 hasConcept C2778409475 @default.
- W2069247891 hasConcept C2779520467 @default.
- W2069247891 hasConcept C2780723003 @default.
- W2069247891 hasConcept C2780795376 @default.
- W2069247891 hasConcept C2909581452 @default.
- W2069247891 hasConcept C42219234 @default.
- W2069247891 hasConcept C71924100 @default.
- W2069247891 hasConcept C84393581 @default.
- W2069247891 hasConcept C98274493 @default.
- W2069247891 hasConceptScore W2069247891C126322002 @default.
- W2069247891 hasConceptScore W2069247891C170493617 @default.
- W2069247891 hasConceptScore W2069247891C2775859210 @default.
- W2069247891 hasConceptScore W2069247891C2776277131 @default.
- W2069247891 hasConceptScore W2069247891C2776312488 @default.
- W2069247891 hasConceptScore W2069247891C2776814716 @default.
- W2069247891 hasConceptScore W2069247891C2776885963 @default.
- W2069247891 hasConceptScore W2069247891C2777953023 @default.
- W2069247891 hasConceptScore W2069247891C2778000748 @default.
- W2069247891 hasConceptScore W2069247891C2778300832 @default.
- W2069247891 hasConceptScore W2069247891C2778409475 @default.
- W2069247891 hasConceptScore W2069247891C2779520467 @default.
- W2069247891 hasConceptScore W2069247891C2780723003 @default.
- W2069247891 hasConceptScore W2069247891C2780795376 @default.
- W2069247891 hasConceptScore W2069247891C2909581452 @default.
- W2069247891 hasConceptScore W2069247891C42219234 @default.
- W2069247891 hasConceptScore W2069247891C71924100 @default.
- W2069247891 hasConceptScore W2069247891C84393581 @default.
- W2069247891 hasConceptScore W2069247891C98274493 @default.
- W2069247891 hasIssue "9" @default.
- W2069247891 hasLocation W20692478911 @default.
- W2069247891 hasLocation W20692478912 @default.
- W2069247891 hasOpenAccess W2069247891 @default.
- W2069247891 hasPrimaryLocation W20692478911 @default.
- W2069247891 hasRelatedWork W2039370589 @default.
- W2069247891 hasRelatedWork W2048896496 @default.
- W2069247891 hasRelatedWork W2063046478 @default.
- W2069247891 hasRelatedWork W2115589714 @default.
- W2069247891 hasRelatedWork W2141269051 @default.
- W2069247891 hasRelatedWork W2398044454 @default.
- W2069247891 hasRelatedWork W2778167326 @default.
- W2069247891 hasRelatedWork W281305292 @default.
- W2069247891 hasRelatedWork W311873106 @default.
- W2069247891 hasRelatedWork W622146696 @default.
- W2069247891 hasVolume "54" @default.
- W2069247891 isParatext "false" @default.
- W2069247891 isRetracted "false" @default.
- W2069247891 magId "2069247891" @default.
- W2069247891 workType "article" @default.